Marinde G. Bond

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Time of Detection of Liver Metastases and Survival in Patients With Colorectal Cancer.

Time of Detection of Liver Metastases and Survival in Patients With Colorectal Cancer.

Journal: JAMA network open

Published: March 17, 2026

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Journal: Annals of surgical oncology

Published: January 04, 2026

Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Journal: Annals of surgical oncology

Published: June 30, 2025

Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial.

Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 16, 2025

Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases.

Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases.

Journal: EBioMedicine

Published: April 28, 2025

One-stage versus two-stage surgery for initially unresectable colorectal cancer liver metastases: post hoc analysis of the CAIRO5 trial.

One-stage versus two-stage surgery for initially unresectable colorectal cancer liver metastases: post hoc analysis of the CAIRO5 trial.

Journal: BJS open

Published: April 25, 2025

Overall Survival in the CAIRO5 Clinical Trial-Reply.

Overall Survival in the CAIRO5 Clinical Trial-Reply.

Journal: JAMA oncology

Published: April 17, 2025

First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial.

First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial.

Journal: JAMA oncology

Published: November 21, 2024

Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment.

Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 28, 2024

Prognostic value of radiologic and pathological response in colorectal cancer liver metastases upon systemic induction treatment: subgroup analysis of the CAIRO5 trial.

Prognostic value of radiologic and pathological response in colorectal cancer liver metastases upon systemic induction treatment: subgroup analysis of the CAIRO5 trial.

Journal: ESMO open

Published: August 27, 2024

Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer.

Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer.

Journal: JCO clinical cancer informatics

Published: July 17, 2024

Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation.

Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 09, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026